Context Therapeutics Financial Overview
Context Therapeutics's market cap is currently $116.69M. The company's EPS TTM is $-0.1; its P/E ratio is -4.54; Context Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
